SynthesisEnvironment international2026
Systematic review and meta-analysis of adverse health effects associated with mycotoxin exposure.
Synthesis in Environment international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMycotoxins, toxic fungal metabolites present in food, are an increasing global health concern expected to intensify with climate change and shifting dietary patterns.
aimThis review systematically identified, appraised, and synthesized primary research on human health effects associated with exposure to single and multiple mycotoxins, aiming to clarify current evidence, uncertainties, and research gaps.
methodsFollowing the PECO framework, Embase, Cochrane Library, PubMed, Web of Science, and Scopus were searched from inception to May 2025 for studies reporting measured or modelled mycotoxin exposure and human health outcomes. Non-human, mechanistic, review, and grey literature were excluded. Three reviewers independently screened studies, with duplicate full-text assessment. Risk of bias was evaluated using OHAT and certainty of evidence with GRADE. Sensitivity analyses, publication bias assessment, and non-quantitative evidence were synthesized using Cochrane effect-direction plots. Random-effects meta-analyses assessed associations between aflatoxin exposure and seven health outcomes.
resultsOf 55,342 records, 268 studies met inclusion criteria, covering 17 mycotoxin groups and 71 health outcomes. Liver disease, particularly hepatocellular carcinoma, and kidney disease were the most frequently investigated outcomes, with most studies conducted in Africa and Asia. Qualitative synthesis demonstrated predominantly positive associations between mycotoxin exposure and neurological, metabolic, oncological, renal, reproductive, and developmental disorders. Certainty of evidence was very low for all 21 assessed outcomes, reflecting the predominance of cross-sectional designs and substantial between-study inconsistency. Quantitative meta-analyses of 42 studies identified associations between aflatoxin exposure and hepatocellular carcinoma, liver cirrhosis, elevated ALT, and gallbladder cancer.
conclusionEvidence supports associations between mycotoxin exposure and multiple health risks; however, heterogeneity in study design, exposure assessment, and outcome reporting highlights the need for more rigorous and harmonized research across diverse populations.
Indexed as
Identifiers
42810138What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.